High success and low recurrence with shorter treatment regimen for multidrug-resistant TB in Nepal

SETTING: Nine drug-resistant TB centres, some of them supported by Damien Foundation in Nepal where >80% of multidrug-resistant/rifampicin-resistant TB (MDR/RR-TB) patients are treated. OBJECTIVE: To assess the uptake, effectiveness and safety of the 9–12-month shorter treatment regimen (STR) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Koirala, S., Shah, N. P., Pyakurel, P., Khanal, M., Rajbhandari, S. K., Pun, T., Shrestha, B., Maharjan, B., Karki, S., Tamang, K. B., Roggi, A., Kumar, A. M. V., Ortuño-Gutiérrez, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union Against Tuberculosis and Lung Disease 2021
Materias:
Amr Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575385/
https://www.ncbi.nlm.nih.gov/pubmed/34778014
http://dx.doi.org/10.5588/pha.21.0041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575385/
https://www.ncbi.nlm.nih.gov/pubmed/34778014
http://dx.doi.org/10.5588/pha.21.0041

Ejemplares similares